Clinical Trials Directory

Trials / Completed

CompletedNCT03422016

Electroretinogram in Autistic Spectrum Disorders

The Incidence of Altered Light Responses in Children With Autistic Spectrum Disorders

Status
Completed
Phase
Study type
Observational
Enrollment
177 (actual)
Sponsor
Great Ormond Street Hospital for Children NHS Foundation Trust · Academic / Other
Sex
All
Age
4 Years – 25 Years
Healthy volunteers
Accepted

Summary

This study aims to find out the incidence of a reduced light adapted electroretinogram (ERG) b-wave amplitude in children with a diagnosis of Autism Spectrum Disorders (ASD).

Detailed description

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition which becomes apparent as children grow. Children with ASD are slow to develop language and have problems interacting socially with others. It is not clear why ASD occurs, but there is some evidence that the signals that tell the brain how to grow are altered which causes the brain to develop and function differently in people with ASD. Eyes develop from the same embryonic tissue as the brain. This means that the retina, which is the light sensitive layer at the back of the eye, shares the same signals as the brain. Investigators can listen to retinal signals outside the eye and the retina can, in this way, act as an accessible part of the brain. The investigators will detect retinal signals as electrical messages. Sensors placed near the eye pick up the electrical changes in the retina each time a light flashes. This non-invasive, routine clinical test is called an electroretinogram, (ERG). The investigators have carried out a study that showed differences in the ERGs recorded from adults with ASD compared to control participants. The main aim of this project is find out how common ERG differences are in children with ASD compared to controls. If it is common, investigators could use the ERG to make an earlier diagnosis of ASD and help families sooner. It could help investigators better understand the way the ASD brain signals and give investigators a way of measuring if therapies work.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTelectroretinogram (ERG)an ERG is a measure of the eyes response to a flash of light

Timeline

Start date
2018-09-03
Primary completion
2020-03-03
Completion
2020-04-03
First posted
2018-02-05
Last updated
2022-01-11

Locations

4 sites across 3 countries: United States, Australia, United Kingdom

Source: ClinicalTrials.gov record NCT03422016. Inclusion in this directory is not an endorsement.